Results 11 to 20 of about 49,397 (289)

Assessing efficacy and safety of buccally inoculated midazolam and intravenously administered diazepam for relieving pediatric primary generalized epileptic seizures

open access: yesЭпилепсия и пароксизмальные состояния, 2021
Objective: to confirm a therapeutic equivalence and similar safety profile of “Midazolam, oromucosal (buccal) solution” and “Sibazon, solution for intravenous and intramuscular administration” used in children aged from 1 year to 18 years suffering from ...
A. G. Prityko   +6 more
doaj   +1 more source

Significant hypotension following buccal midazolam administration [PDF]

open access: yesBMJ Case Reports, 2010
Buccal midazolam is a rescue medication to reduce the duration of or stop an epileptic seizure, and is used to prevent status epilepticus. It is available in various forms, including a buccal preparation with a strength of 10 mg/1 ml. Midazolam is a licensed medication, but the buccal formulation is currently used off-licence.
Sanjay M. Sisodiya   +2 more
openaire   +3 more sources

Factors affecting the buccal delivery of deformable nanovesicles based on insulin–phospholipid complex: an in vivo investigation

open access: yesDrug Delivery, 2020
Deformable nanovesicles (DNVs) have been used in the buccal delivery of biomacromolecules due to their ability to enhance drug penetration. However, no breakthroughs have been made until now due to limited understanding of the factors affecting in vivo ...
Yuqi Yang   +6 more
doaj   +1 more source

The Potential of Films as Transmucosal Drug Delivery Systems

open access: yesPharmaceutics, 2023
Pharmaceutical films are polymeric formulations used as a delivery platform for administration of small and macromolecular drugs for local or systemic action.
Ana Clara Wada de Carvalho   +6 more
doaj   +1 more source

Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation

open access: yesPharmaceutics, 2021
The reduced therapeutic efficacy of rizatriptan in migraine treatment is primarily due to low oral bioavailability and extensive first pass metabolism. The purpose of this investigation was to optimize the thin mucoadhesive buccal film of rizatriptan and
Anroop B. Nair   +6 more
doaj   +1 more source

Incorrect administration of buccal glyceryl trinitrate [PDF]

open access: yesHeart, 2002
A 66 year old man with documented coronary artery disease was brought by ambulance to the emergency department with severe anginal chest pain and pulmonary oedema. Two 2 mg buccal glyceryl trinitrate …
L Michaels, Alan Hugh David Watson
openaire   +2 more sources

Absolute Bioavailability of Microdosed Midazolam After Buccal Administration Is Dependent on Buccal Exposure Time [PDF]

open access: yesThe Journal of Clinical Pharmacology, 2020
AbstractMidazolam is an established probe drug to assess cytochrome P450 3A activity (phenotyping). Microdosed midazolam is increasingly used for this purpose; a buccal formulation might be of advantage, but buccal absorption might occur. We therefore tested in a single‐center, open‐label clinical trial with 12 healthy volunteers the absolute ...
Jana Grass   +5 more
openaire   +3 more sources

Survey of Provider Preferences Regarding the Route of Misoprostol for Induction of Labor at Term

open access: yesAmerican Journal of Perinatology Reports, 2017
Objective To survey obstetrical provider preferences regarding use of misoprostol for induction of labor (IOL). Methods An anonymous 25-question survey was distributed at an American College of Obstetricians and Gynecologists (ACOG) joint ...
Rachel Towns   +3 more
doaj   +1 more source

Midazolam pharmacokinetics following intravenous and buccal administration [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1998
Aims  Midazolam has good anxiolytic qualities and is a well established premedication agent before anaesthesia or short surgical procedures. The objective of the present study was to determine pharmacokinetic data from individual plasma concentration profiles obtained following intravenous and buccal administration of midazolam.
S. Alincic   +2 more
openaire   +3 more sources

The administration of multipotent stromal cells at precancerous stage precludes tumor growth and epithelial dedifferentiation of oral squamous cell carcinoma [PDF]

open access: yes, 2017
Multipotent stromal cells (MSCs) are envisioned as a powerful therapeutic tool. As they home into tumors, secrete trophic and vasculogenic factors, and suppress immune response their role in carcinogenesis is a matter of controversy.
Arango Rodríguez, Martha   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy